Indaba Capital Management, L.P.
Follow13F filer, CIK 1524362, SAN FRANCISCO, CA
Indaba Capital Management, L.P. reported $233,708,134 across 9 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001011438-24-000663
- Period
- 2024-09-30
- Reported value
- $234M
- Holdings
- 9
- Top 10 weight
- 100%
- New
- 3
- Sold out
- 1
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| EQCadded | +2,000,000 | $39.8M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| BLexited | -292,000 | -$14.1M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2024
Share positions as resolved from 13F-HR 0001011438-24-000663, largest first. % of portfolio is the value over $233,708,134, the sum of the share positions whose value is usable for ratios (method).
Principal amounts
Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| Esperion Therapeutics IncEsperion Therapeutics Inc NOTE 4.000%11/15/25 | principal | 33,750,000 | $32M | +32,750,000 |
| BANDWIDTH INCBANDWIDTH INC NOTE 0.500% 4/0 | principal | 40,250,000 | $31.4M | -9,000,000 |
| XOMETRY INCXOMETRY INC NOTE 1.000% 2/0 | principal | 21,750,000 | $18.6M | +4,000,000 |
| ACCELERATE DIAGNOSTICS INCACCELERATE DIAGNOSTICS INC NOTE 5.000%12/1 | principal | 24,083,901 | $12.4M | 0 |
| IRONWOOD PHARMACEUTICALS INCIRONWOOD PHARMACEUTICALS INC NOTE 1.500% 6/1 | principal | 9,000,000 | $7.96M | new |
| STANDARD BIOTOOLS INCSTANDARD BIOTOOLS INC NOTE 5.250%12/0 | principal | 7,660,000 | $7.63M | new |
| SUMMIT HOTEL PPTYSSUMMIT HOTEL PPTYS NOTE 1.500% 2/1 | principal | 4,500,000 | $4.25M | new |
Sold out in Q3 2024
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| BLBLACKLINE INC | 292,000 | $14.1M | shares |
How Q3 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001011438-24-000663 | base | 2024-11-14 | acceptance time not in the bulk data set |